Difference between revisions of "Team:Lethbridge/HP/Gold Integrated"

Line 52: Line 52:
 
    
 
    
 
     <tr id="row2">
 
     <tr id="row2">
         <td><a href="https://static.igem.org/mediawiki/2017/b/ba/LB_Media.pdf" target="_blank"><img src="https://static.igem.org/mediawiki/2017/7/78/T--Lethbridge--sgtnv.png" width=360px; height=480px; /></a></td>
+
         <td><a href="https://static.igem.org/mediawiki/2017/5/56/T--Lethbridge--TxTl_student.pdf" target="_blank"><img src="https://static.igem.org/mediawiki/2017/7/78/T--Lethbridge--sgtnv.png" width=360px; height=480px; /></a></td>
 
         <td><a href="https://static.igem.org/mediawiki/2017/b/ba/LB_Media.pdf" target="_blank"><img src="https://static.igem.org/mediawiki/2017/0/08/T--Lethbridge--tgtnv.png" alt="Hobbyist" width=360px; height=480px; style="padding-left: 5px;"></a></td>
 
         <td><a href="https://static.igem.org/mediawiki/2017/b/ba/LB_Media.pdf" target="_blank"><img src="https://static.igem.org/mediawiki/2017/0/08/T--Lethbridge--tgtnv.png" alt="Hobbyist" width=360px; height=480px; style="padding-left: 5px;"></a></td>
 
         <td><a href="https://static.igem.org/mediawiki/2017/b/ba/LB_Media.pdf" target="_blank"><img src="https://static.igem.org/mediawiki/2017/e/e8/T--Lethbridge--bsm.png" alt="Expert" width=360px; height=480px;></a></td>
 
         <td><a href="https://static.igem.org/mediawiki/2017/b/ba/LB_Media.pdf" target="_blank"><img src="https://static.igem.org/mediawiki/2017/e/e8/T--Lethbridge--bsm.png" alt="Expert" width=360px; height=480px;></a></td>

Revision as of 21:53, 29 October 2017

Our gold and integrated practices became two large components this year as we took into consideration what our user groups needed us to provide and how we could ensure that we would be providing a safe tool. Based on our conversations with educators and members of the DIY Biology community, we decided to focus on education as an application of our cell-free system. To ensure our system would be safe and be available for people to use around the world, we explored the regulations surrounding synthetic biology and cell-free systems. We also discovered a potential dual-use of our system and came up with a solution to this using software.


Education Kit

Taking into account the suggestions we received from the interviews we conducted with various educators , we have developed a simple experiment that aligns with the Alberta Biology 30 curriculum (ref to Unit C document). The experiments uses the fluorescence capabilities of RNA Mango to indicate when transcription has occurred and the chemical reaction between salicylic acid and the protein BMST1 ( BBa_K1403009 ) to produce a wintergreen scent to indicate translation. Derek Masterman suggested that we use physical indicators to ensure students understand that processes are separate. During the development of this experiment we received feedback from the students on the Lethbridge High School iGEM Team, one of our team members who is the education program at the University of Lethbridge, and biology teachers from Winston Churchill High School.

In addition to the transcription and translation protocol, we also developed a biosafety module. We designed this module based off of our conversation with the Public Health Agency of Canada . They suggested that students need to understand how to interact with microorganisms at an early age to mitigate the risk of lab incidents in the future.

In the future, we hope that we can develop more experiments that utilize a cell-free system. We plan on doing some work within our lab to test sub-optimal reaction conditions for these experiments. We plan on doing a more in depth analysis of how these experiments can also align with STEAM (Science, Technology, Engineering, Arts, and Mathematics) initiatives to complement the Lethbridge High School iGEM Team's proposal . We also wish to develop an intermediate level of protocols to better suite the needs of the DIY Biology community members that we spoke with. We received feedback on this module from the Lethbridge High School iGEM Students, our team member, and high school teachers.






Check out the full modules below!



Professional Development

Within education, professional development (PD) days are defined as a variety of specialized training sessions to help administrators and teachers improve their ability to teach (ref). To better integrate synthetic biology concepts within the existing Alberta curriculum, the teachers we spoke with suggested that PD days would be an effective way to ensure that teachers understand the concepts to effectively teach students. Our team paired up with SynBridge, a makerspace located in the University of Lethbridge to begin the process of hosting these workshops. Our team will work on designing the workshops to be held on the PD days, with SynBridge providing the space to host them and acting as a resource for teachers after our iGEM season has ended.

We met with Emily Wilton, the coordinator for SynBridge, to discuss how we would work on the design of the Professional Development Day workshops. Emily told us that they would like to provide the workshops free of charge or at a subsidized rate for the schools, which help to accommodate the limited teaching budgets. We would also work on the design of experiments to teach, while keeping in contact with teachers to ensure they would meet the curriculum needs.

When we discussed our plans with the Winston Churchill Science Department, the best direction to have the PD days instilled was discussed. They suggested forming a collaborative community. In Alberta, a collaborative community is defined as a group of teachers being able to focus on any one school related topic and is open for any teacher to join. Moving forward in this direction, this would also allow these PD days to be open to the whole school district in Lethbridge.

The teachers are planning on visiting SynBridge facilities on April 9th and plan on using this visit to move forward with the development of more synthetic biology initiatives in their curriculum. We plan on this being a long-term goal to be continued on after our season has ended.




Regulation Research

To understand if synthetic biology products and cell-free systems were regulated around the world, we researched relevant legislation. Table 1 is an overview of the regulations that we could find that are implemented in the four legal systems used as was suggested to us by Ian Andrews . We concluded that some legal systems have more concrete regulations for the use of products derived using biotechnology. Most countries have in place some form of assessments to ensure that any products will not have detrimental effects on the environment and human health.




Figure 1. Colour-coded depiction of countries by type of legal system.



Table 1. Overview of regulations related to the implementation of biotechnology and organismal based devices in society by legal system.

Legal System Civil Common Mixed Religious
Laboratory Safety General guidelines implemented,
national frameworks being updated
General guidelines implemented in regulations,
committees in place to oversee concerns
General guidelines implemented in regulations,
committees in place to oversee concerns
National biosafety frameworks in the process of being developed, have signed the
Cartagena Protocol
GMO Regulations In place, appropriate labelling required in most cases to identify GMO status
Generally strict regulations in place (EU, JPN)
In place, usage differs depending on country though most countries allow (notable exception: NZ) Dependent on country: some follow EU regulations and restrict access while others are in the process of
developing legislation with minimal regulations currently
In place, only allow certain crops, need proper labelling to identify GMO status
Environmental Regulations Environmental impact assessments used to determine effect on biological diversity,
environmental release addressed
Environmental impact assessments used to determine effect on biological diversity, environmental release addressed Environmental impact assessments used to determine effect on biological diversity, some countries have in place
environmental release stipulations
Environmental impact assessments used to determine effect on biological diversity,
developing more specific legislation for environmental release
Agricultural Regulations Regulations mostly relate to field trials Must be approved by regulatory body to not cause a
negative impact on the environment
Dependent on country: some have strict regulations on crops
that can be planted while others have regulations in place, but allow a greater crop diversity
Regulations relate to type of crops that can be planted
Health Regulations Must be approved by governing authority to not have negative impacts Must be approved by governing authority to not have negative impacts Must be approved by governing authority to not have negative impacts, some countries are still in the process
of developing legislation
In development with the growth of biotechnology, general
regulations state that new materials generated must be approved

We looked further into the regulations of biotechnology products in Canada and the United and tried to find any piece of legislation that mentioned the regulations of cell-free systems. Within Canada and the United States, both countries do not regulate the methodology of how products are made; they focus on the end materials. While we could not find any specific mention of "cell-free", Ian was able to clarify within our interview with him as to why we were unable to find any direct mentions. However, the closest piece of legislation that we could find that was the most associated with our project is the Assisted Human Reproduction Act in Canada as it prohibits transplanting human-based materials into non-human life forms.

Table 2. Canadian and American Regulation Comparisons for Cell-Free Systems.

Regulation Area Canada United States
Health Assisted Human Reproduction Act (HC):
    Focus on IVF and new technologies that can aid in reproduction
    Transplantation into a non-human life form is prohibited
Federal Food, Drug, and Cosmetic Act (FDA)
Public Health Service Act (FDA):
    All biological products must go through licensing process before introduction
Environment Canadian Environmental Protection Act (EC and HC):
    Focus on environmental release and new organism activity
    Environmental assessment required and notification of agencies
National Environment Policy Act (EPA):
    Requires environmental assessments to determine the impact on the environment
Food/Pharmaceuticals Food and Drugs Act (CFIA):
    Focus on labelling and notification of marketing
    Director must receive notification of intent to sell modified products including an extensive report
Federal Food, Drug, and Cosmetic Act (FDA)
Public Health Service Act (FDA) :
    Must be approved by FDA if food is an additive, but mislabelled food is prohibited
    New Drug Application submitted for approval to go to marker
Agriculture Seeds Act (CFIA)
Canada Agricultural Products Act (CFIA):
    Planting, importation, and transportation regulated
    Must have proof to not cause harm to humans or the environment
Federal Seed Act (APHIS)
Plant Protection Act (APHIS) :
    Planting, importation, and transportation regulated
    Must have approval before plant is introduced
Pests Pest Control Products Act (PMRA):
    Accepted if there is proof that no human health will not be affected or will have long term effects on the environment
Federal Insecticide, Fungicide, and Rodenticide Act (EPA):
    Registration process detailing proof no harm to the environment
Microorganisms Canadian Environmental Protection Act (EC and HC):
    Undergo screening assessment to identify potential harm to humans and the environment
Toxic Substances Control Act (EPA):
    Must submit notice of use with information on organism
Animals Health of Animals Act (CFIA):
    Prohibited to introduce substances without permit
Federal Food, Drug, and Cosmetic Act (FDA):
    Focusses more on using novel drugs in animal trials
    Must fill out application detailing effects on the animal and the environment
Pathogens and Toxins Human Pathogens and Toxins Act (PHAC):
    Regulates Risk Group 2-4 organisms
    Prohibited from producing toxins and pathogens within Schedules without a licence
Toxic Substances Control Act (EPA):
    Does not classify toxic and non-toxic chemicals
    Chemicals not on list are prohibited from being produced
Table 2 abbreviations
    HC: Health Canada
    EC: Environment Canada
    CFIA: Canadian Food Inspection Agency
    PMRA: Pest Management Regulatory Agency
    PHAC: Public Health Agency of Canada
    FDA: Federal Food and Drug Agency
    EPA: Environmental Protection Agency
    APHIS: Animal and Plant Health Inspection Service


Biocontainment

Since our cell-free system has the ability to rapidly purify the essential components to produce an output protein and does not contain genomic DNA, it has an application in aiding genetic recoding research. Genetic recoding is observed when the relationship between codons on the mRNA strand and the tRNA carrying an amino acid change. Traditionally, the majority of living systems utilize the standard 64 codon table to produce proteins.

However, with our system’s ability to alter the normal interactions that occur to produce the standard code, we can generate modified codon tables. The generation of modified codon tables can provide another feature to our system to make it intrinsically safe. By altering our system to only read a modified code, it prevents environmental sequences from contaminating our system modified inputs from being transferred to living organisms and/or modified inputs from being transferred to living organisms. This prevents accidental environmental contamination being introduced by our system. From the research we conducted within environmental regulations, our system becomes more in-line with current regulations and their aim to ensure that synthetic biology produced products do not have a detrimental effect on the environment.

References

  • [1] Alberta Education. (2008). Biology 30 [Unit C]. Edmonton, Canada: Alberta Learning.
  • [2] Liberty Concepts (2013, August 29). Professional Development Definition. Retrieved August 23, 2017, from http://edglossary.org/professional-development/.
  • [3] Andanda, P., Status of Biotechnology Policies in South Africa, Asian Biotechnology and Development Review, 2009. 11(3): 35-47.
  • [4] Application of Biotechnology in Human Medicine, etc. Act 1987 (Fed) (NOR)
  • [5] Assisted Human Reproduction Act 2004 (Fed) (CAN).
  • [6] Bielecka, A. and A. A. Mohammadi, State-of-the-Art in Biosafety and Biosecurity in European Countries. Archivum Immunologiae et Therapiae Experimentalis, 2014. 62: 169-178.
  • [7] Biosafety Act 2009 (Fed) (KEN).
  • [8] Canada Agricultural Products Act 1985 (Fed) (CAN).
  • [9] Canadian Environmental Protection Act 1999 (Fed) (CAN).
  • [10]Carter, S. R., M. Rodemeyer, M. S. Garfinkel, R. M. Friedman, Synthetic Biology and the U.S. Biotechnology Regulatory System: Challenges and Options. J. Craig Venter Institute, 2014.
  • [11] Federal Food, Drug, and Cosmetic Act 1938 (Fed) (USA).
  • [12] Federal Insecticide, Fungicide, and Rodenticide Act 1910 (Fed) (USA).
  • [13] Federal Seed Act 1939 (Fed) (USA).
  • [14] Food and Drugs Act 1985 (Fed) (CAN).
  • [15] Global Legal Research Center. Restrictions on Genetically Modified Organisms. Law Library of Congress, 2014.
  • [16] Gupta, K., J. L. Karihaloo, and R. K. Khetarpal, Biosafety Regulations of Asia-Pacific Countries. Asia-Pacific Association of Agricultural Research Institutions, Bangkok; Asia-Pacific Consortium on Agricultural Biotechnology, New Delhi and Food and Agricultural Organization of the United Nations, Rome, 2008. P. 108 + i-x.
  • [17] Health of Animals Act 1990 (Fed) (CAN).
  • [18] Horng, D., International Law on Biotechnology. International Law and Institutions, 2006.
  • [19] Human Pathogens and Toxins Act 2009 (Fed)(CAN).
  • [20] Komen, J., The Emerging International Regulatory Framework for Biotechnology. GM Crops and Food, 2012. 3(1): 78-84.
  • [21] LaVan, D. A. and L. M. Marmon, Safe and Effective Synthetic Biology. Nature Biotechnology, 2010. 21(10): 1010-1012.
  • [22] Lee-Jones, D., New Zealand Agricultural Biotechnology Annual, 2016.
  • [23] Mahboudi, F., H. Hamedifar, and H. Aghajani, Medical Biotechnology Trends and Achievements in Iran. Medical Biotechnology, 2012. 4(4): 200-205.
  • [24] Martella, R. R. and J. B. Grosko, ed., International Environmental Law: The Practitioner’s Guide to the Laws of the Planet. USA, 2014. 20: 365-395.
  • [25] Mousa, H. Saudi Arabia Agricultural Biotechnology Annual, 2016.
  • [26] National Biosafety Framework 2004 (Fed) (IRN).
  • [27] National Environmental Policy Act 1970 (Fed) (USA).
  • [28] National Health Act 2003 (Fed) (RSA).
  • [29] Ndihokubwayo, J. B, The Current State of Biosafety in the African Region, Biosafety Global Stakeholders Meeting, September 23-24, 2015, Atlanta, GA.
  • [30] Patterson, L. A. and T. Josling. Regulating Biotechnology: Comparing E.U. and U.S. Approaches. Transatlantic Biotech.
  • [31] Pest Control Products Act 2002 (Fed) (CAN).
  • [32] Plant Protection Act 2000 (Fed) (USA).
  • [33] Public Health Service Act 1944 (Fed) (USA).
  • [34] Science for Environment Policy (2016) Synthetic Biology and Biodiversity. Future Brief 15. Produced for the European Commission DG Environment by the Science Communication Unit, UWE, Bristol.
  • [35] Secretariat of the Convention on Biological Diversity (2000). Cartagena Protocol on Biosafety to the Convention on Biological Diversity: text and annexes. Montreal: Secretariat of the Convention on Biological Diversity.
  • [36] Seeds Act 1985 (Fed)(CAN).
  • [37] Sorj, B., M. Cantley, and K. Simpson ed. Biotechnology in Europe and Latin America Prospects for Co-Operation. Edelstein Center for Social Research, Rio de Janeiro, 2010. P. 1-211.
  • [38] Swanby, H., On-going Concerns about Harmonisation of Biosafety Regulations in Africa, 2009. 11: 3-12.
  • [39] Toxic Substances Control Act 1976 (Fed) (USA).